CLINICAL_TRIALS trial_result · 2020-12-01

Clinical Trial Update: Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal [Phase 4]

Phase 4 clinical trial evaluating withdrawal of calcineurin inhibitors in kidney transplant recipients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University at Buffalo | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2020-12-01